Skip to main content

Table 1 Summary of data in patients with thyroid lesion

From: Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study

Patient

Age

Sex

Preoperative clinical diagnosis

Pathological diagnosis

gGlu-HMRG*a lesion normal

1

30

F

PTC*b

PTC

positive

negative

2

32

F

PTC

PTC

positive

negative

3

46

F

PTC (recurrence)

PTC(recurrence)

positive

negative

4

55

F

Thyroid malignant tumor

Mediastinal goiter

negative

negative

5

78

M

Lymphoma

Inflammation

negative

negative

6

43

F

PTC

PTC

positive

negative

7

47

F

Thyroid tumor

Follicular adenoma

negative

negative

8

47

F

PTC

PTC

positive

negative

9

44

F

PTC

PTC

positive

negative

10

61

F

PTC

PTC

positive

negative

11

32

F

PTC

PTC

positive

negative

12

48

M

PTC

PTC

positive

negative

13

23

F

Thyroid tumor

Goiter*c

negative

negative

14

44

M

PTC

PTC

positive

negative

15

58

F

Thyroid tumor

Goiter

negative

negative

16

72

F

PTC

PTC

positive

negative

17

57

M

PTC

PTC

positive

negative

18

68

F

Thyroid lesion

Graves’*d

negative

negative

19

71

F

PTC

PTC

negative

negative

20

55

F

PTC

PTC

positive

negative

21

52

F

PTC

PTC

positive

negative

22

69

M

Goiter

Goiter

negative

negative

23

64

M

PTC

PTC

positive

negative

  1. *agGlu-HMRG: detection results by using γ- glutamyl hydroxymethyl rhodamine green, *bPTC: Papillary thyroid carcinoma,
  2. *cGoiter: Adenomatous goiter, *dGraves’: Graves’ disease or Basedow disease